UNSPSC 51412604: Ledazerol

This classification denotes a vasodilating agent with the molecular formula C11H12N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P13OO3FPZB, chemically known as benzenemethanol, 2-hydroxy-3-(1h-imidazol-4-ylmethyl)- but generally known as ledazerol, which bears US NIH Compound Identifier 65932. European Medicines Agency schedules Ledazerol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08420MIG.

UNSPSC 51412604 Ledazerol, a Commodity code, represents pharmaceutical procurement activity at the state and local level, though the recent solicitation record shows minimal direct activity under this specific code designation. State and local governments soliciting under this code are primarily acquiring advanced life support medications and generic pharmaceuticals for emergency medical services, public health agencies, and cooperative purchasing networks. The City of Tampa's Purchasing Department and the Texas Health and Human Services Commission represent the issuing-body mix, with participation from cooperative purchasing alliances such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP). These solicitations demonstrate that governments buy finished pharmaceutical products — including emergency cardiac and vasopressor medications, generic multi-source pharmaceuticals, and over-the-counter products — with specific requirements for cGMP compliance, FDA registration, expiration dating standards (typically nine months to one year from acceptance), Safety Data Sheets per OSHA requirements, and delivery within constrained timeframes.

Recent activity centers in Florida, Texas, and Minnesota. The City of Tampa issued IFB No. 26P00188 for Advanced Life Support Medications on April 24, 2026, with a due date of April 8, 2026, soliciting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response date, requiring compliance with Drug Supply Chain Security Act certification and distribution through authorized wholesalers including AmerisourceBergen, Cardinal Health, and Morris & Dickson. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional PBM and GPO channels, though this represents exploratory procurement rather than a formal solicitation.